These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34637943)

  • 1. Concurrent pathogenic variations in patients with hereditary cancer syndromes.
    Agaoglu NB; Doganay L
    Eur J Med Genet; 2021 Dec; 64(12):104366. PubMed ID: 34637943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of germline mutations in northern Brazil: a panel of 16 genes for hereditary cancer-predisposing syndrome investigation.
    Vidal AF; Ferraz RS; El-Husny A; Silva CS; Vinasco-Sandoval T; Magalhães L; Raiol-Moraes M; Barra WF; Pereira CLBL; de Assumpção PP; de Brito LM; Vialle RA; Santos S; Ribeiro-Dos-Santos Â; Ribeiro-Dos-Santos AM
    BMC Cancer; 2021 Apr; 21(1):363. PubMed ID: 33827469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent Pathogenic Variants of BRCA1, MUTYH and CHEK2 in a Hereditary Cancer Family.
    Agaoglu NB; Ng OH; Unal B; Dogan OA; Amanvermez U; Yildiz J; Doganay L; Ghazani AA; Rana HQ
    Cancer Genet; 2022 Nov; 268-269():128-136. PubMed ID: 36368126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New germline mutations in BRCA1, ATM, MUTYH, and RAD51D genes in Tuvans early-onset breast cancer patients.
    Gervas P; Molokov A; Ivanova A; Panferova Y; Kiselev A; Chernyshova A; Pisareva L; Choynzonov E; Cherdyntseva N
    Exp Oncol; 2021 Mar; 43(1):52-55. PubMed ID: 33785725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
    Tsaousis GN; Papadopoulou E; Apessos A; Agiannitopoulos K; Pepe G; Kampouri S; Diamantopoulos N; Floros T; Iosifidou R; Katopodi O; Koumarianou A; Markopoulos C; Papazisis K; Venizelos V; Xanthakis I; Xepapadakis G; Banu E; Eniu DT; Negru S; Stanculeanu DL; Ungureanu A; Ozmen V; Tansan S; Tekinel M; Yalcin S; Nasioulas G
    BMC Cancer; 2019 Jun; 19(1):535. PubMed ID: 31159747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary Cancer Syndrome in a Family with Double Mutation in
    D'Elia G; Caliendo G; Passariello L; Albanese L; Makker J; Molinari AM; Vietri MT
    Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double heterozygous mutation in the BRCA1 and ATM genes involved in development of primary metachronous tumours: a case report.
    Andrés R; Menao S; Arruebo M; Quílez E; Cardiel MJ
    Breast Cancer Res Treat; 2019 Oct; 177(3):767-770. PubMed ID: 31292799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunistic testing of BRCA1, BRCA2 and mismatch repair genes improves the yield of phenotype driven hereditary cancer gene panels.
    Feliubadaló L; López-Fernández A; Pineda M; Díez O; Del Valle J; Gutiérrez-Enríquez S; Teulé A; González S; Stjepanovic N; Salinas M; Capellá G; Brunet J; Lázaro C; Balmaña J;
    Int J Cancer; 2019 Nov; 145(10):2682-2691. PubMed ID: 30927264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2.
    Schoolmeester JK; Moyer AM; Goodenberger ML; Keeney GL; Carter JM; Bakkum-Gamez JN
    Hum Pathol; 2017 Dec; 70():14-26. PubMed ID: 28709830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic mosaics in hereditary tumor predisposition syndromes.
    Steinke-Lange V; de Putter R; Holinski-Feder E; Claes KB
    Eur J Med Genet; 2021 Dec; 64(12):104360. PubMed ID: 34655802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multigene Panel Testing in Turkish Hereditary Cancer Syndrome Patients.
    Arslan Ates E; Turkyilmaz A; Alavanda C; Yildirim O; Guney AI
    Medeni Med J; 2022 Jun; 37(2):150-158. PubMed ID: 35734982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
    Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
    Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
    Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J;
    Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women.
    Kurian AW; Hughes E; Handorf EA; Gutin A; Allen B; Hartman AR; Hall MJ
    JCO Precis Oncol; 2017 Nov; 1():1-12. PubMed ID: 35172496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benchmarking of Whole Exome Sequencing and Ad Hoc Designed Panels for Genetic Testing of Hereditary Cancer.
    Feliubadaló L; Tonda R; Gausachs M; Trotta JR; Castellanos E; López-Doriga A; Teulé À; Tornero E; Del Valle J; Gel B; Gut M; Pineda M; González S; Menéndez M; Navarro M; Capellá G; Gut I; Serra E; Brunet J; Beltran S; Lázaro C
    Sci Rep; 2017 Jan; 7():37984. PubMed ID: 28050010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherited DNA repair gene mutations detected by tumor next generation sequencing in urinary tract cancers.
    Gupta S; Greenberg S; Grimmett J; Gaston D; Agarwal N; Lowrance W; Schiffman J; Kohlmann W
    Fam Cancer; 2017 Oct; 16(4):545-550. PubMed ID: 28315974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hereditary breast carcinomas pathologist's perspective].
    Vincent-Salomon A; Bataillon G; Djerroudi L
    Ann Pathol; 2020 Apr; 40(2):78-84. PubMed ID: 32241645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history of a combined defect in MSH6 and MUTYH in a HNPCC family.
    van Puijenbroek M; Nielsen M; Reinards TH; Weiss MM; Wagner A; Hendriks YM; Vasen HF; Tops CM; Wijnen J; van Wezel T; Hes FJ; Morreau H
    Fam Cancer; 2007; 6(1):43-51. PubMed ID: 17039270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.